These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32643564)

  • 1. CFIm25 in Solid Tumors: Current Research Progress.
    Sun X; Li J; Sun X; Liu W; Meng X
    Technol Cancer Res Treat; 2020; 19():1533033820933969. PubMed ID: 32643564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor "CFIm25".
    Tamaddon M; Shokri G; Hosseini Rad SMA; Rad I; Emami Razavi À; Kouhkan F
    Sci Rep; 2020 Jul; 10(1):11608. PubMed ID: 32665581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3' ends.
    Liu L; Manley JL
    RNA; 2024 Aug; 30(9):1122-1140. PubMed ID: 38986572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
    Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
    Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
    PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer.
    Pagani G; Gandellini P
    Cancer Gene Ther; 2024 Jul; 31(7):957-960. PubMed ID: 38632357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPSF30 at the Interface of Alternative Polyadenylation and Cellular Signaling in Plants.
    Chakrabarti M; Hunt AG
    Biomolecules; 2015 Jun; 5(2):1151-68. PubMed ID: 26061761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
    Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
    [No Abstract]   [Full Text] [Related]  

  • 13. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
    Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
    J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent molecular insights into canonical pre-mRNA 3'-end processing.
    Sun Y; Hamilton K; Tong L
    Transcription; 2020 Apr; 11(2):83-96. PubMed ID: 32522085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Binding Protein CELF2 Regulates Signal-Induced Alternative Polyadenylation by Competing with Enhancers of the Polyadenylation Machinery.
    Chatrikhi R; Mallory MJ; Gazzara MR; Agosto LM; Zhu WS; Litterman AJ; Ansel KM; Lynch KW
    Cell Rep; 2019 Sep; 28(11):2795-2806.e3. PubMed ID: 31509743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Cutting Edge: Regulation and Therapeutic Potential of the mRNA 3' End Nuclease.
    Liu H; Moore CL
    Trends Biochem Sci; 2021 Sep; 46(9):772-784. PubMed ID: 33941430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of CPSF active in polyadenylation: recognition of the polyadenylation signal by WDR33.
    Schönemann L; Kühn U; Martin G; Schäfer P; Gruber AR; Keller W; Zavolan M; Wahle E
    Genes Dev; 2014 Nov; 28(21):2381-93. PubMed ID: 25301781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.